Changes in use of glucose-lowering drugs and physician responsibility: A Danish nationwide study

被引：0
|
作者：
Pottegard, Anton [1 ]
Thomsen, Reimar [2 ]
Andersen, Jacob Harbo [1 ]
Sondergaard, Jens [3 ]
Vilsboll, Tina [4 ]
机构：
[1] Univ Southern Denmark, Odense, Denmark
[2] Aarhus Univ, Aarhus, Denmark
[3] Univ Southern Denmark, Dept Publ Hlth, Res Unit Gen Practice, Odense C, Denmark
[4] Univ Copenhagen, Gentofte Hosp, Ctr Diabet Res, Hellerup, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
416
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [11] Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a Danish nationwide cohort study
    Funck, Kristian Lokke
    Bjerg, Lasse
    Isaksen, Anders Aasted
    Sandbaek, Annelli
    Grove, Erik Lerkevang
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [12] Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a Danish nationwide cohort study
    Kristian Løkke Funck
    Lasse Bjerg
    Anders Aasted Isaksen
    Annelli Sandbæk
    Erik Lerkevang Grove
    Cardiovascular Diabetology, 21
  • [13] Nationwide Trends in Glucose-Lowering Drug Use in Denmark, 1999-2014
    Christensen, Diana H.
    Rungby, Jorgen
    Thomsen, Reimar W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 638 - 639
  • [14] Nationwide trends in glucose-lowering drug use, Denmark, 1999-2014
    Christensen, Diana Hedevang
    Rungby, Jorgen
    Thomsen, Reimar Wernich
    CLINICAL EPIDEMIOLOGY, 2016, 8 : 381 - 387
  • [15] Perioperative Management of Glucose-lowering Drugs: Comment
    Thiruvenkatarajan, Venkatesan
    Jesudason, David
    Nanjappa, Nagesh
    Meyer, Emily Jane
    Van Wijk, Roelof M.
    ANESTHESIOLOGY, 2021, 134 (02) : 349 - 350
  • [16] Influence of Telmisartan on the Metabolism of Glucose-Lowering Drugs
    Li, Jian-Hui
    LATIN AMERICAN JOURNAL OF PHARMACY, 2018, 37 (03): : 484 - 488
  • [17] Cardiovascular safety concerns of glucose-lowering drugs
    Scholze J.
    MMW - Fortschritte der Medizin, 2017, 159 (1) : 62 - 66
  • [18] Glucose-lowering drugs: balancing risks and benefits
    不详
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (09): : 669 - 669
  • [19] Cardiovascular Outcome Trials with Glucose-Lowering Drugs
    Tina K. Thethi
    Anika Bilal
    Richard E. Pratley
    Current Cardiology Reports, 2021, 23
  • [20] Cardiovascular Outcome Trials with Glucose-Lowering Drugs
    Thethi, Tina K.
    Bilal, Anika
    Pratley, Richard E.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (07)
12345